1. Home
  2. WKHS vs MYO Comparison

WKHS vs MYO Comparison

Compare WKHS & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

HOLD

Current Price

$2.99

Market Cap

40.3M

ML Signal

HOLD

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$1.15

Market Cap

33.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKHS
MYO
Founded
2007
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.3M
33.3M
IPO Year
2008
2017

Fundamental Metrics

Financial Performance
Metric
WKHS
MYO
Price
$2.99
$1.15
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$21.00
$7.67
AVG Volume (30 Days)
170.7K
952.9K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
86.92
N/A
EPS
N/A
N/A
Revenue
$763,173.00
$1,000,000,000.00
Revenue This Year
$89.23
$9.10
Revenue Next Year
$28.84
$13.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40814.79
52 Week Low
$0.53
$0.61
52 Week High
$11.80
$2.89

Technical Indicators

Market Signals
Indicator
WKHS
MYO
Relative Strength Index (RSI) 43.44 53.82
Support Level $2.81 $0.71
Resistance Level $4.18 N/A
Average True Range (ATR) 0.37 0.16
MACD -0.08 0.01
Stochastic Oscillator 3.75 34.13

Price Performance

Historical Comparison
WKHS
MYO

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric vehicles, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

Share on Social Networks: